HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gail M Verge Selected Research

NBI 31772

10/2003Neuroprotective effects of insulin-like growth factor-binding protein ligand inhibitors in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gail M Verge Research Topics

Disease

2Ischemia
06/2005 - 10/2003
1Autoimmune Diseases (Autoimmune Disease)
02/2006
1Inflammation (Inflammations)
09/2004
1Neuralgia (Stump Neuralgia)
09/2004
1Pain (Aches)
09/2004
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
10/2003
1Brain Edema (Cerebral Edema)
10/2003
1Brain Ischemia (Cerebral Ischemia)
10/2003
1Infarction (Infarctions)
10/2003

Drug/Important Bio-Agent (IBA)

1class-I restricted T cell-associated moleculeIBA
02/2006
1benzyloxyaspartate (TBOA)IBA
06/2005
13- aminotricyclo(2.2.1.02.6)heptane- 1,3- dicarboxylic acidIBA
06/2005
1Chemokine CX3CL1IBA
09/2004
1CX3C Chemokine Receptor 1IBA
09/2004
1CytokinesIBA
09/2004
1Insulin-Like Growth Factor I (IGF-1)IBA
10/2003
1Insulin-Like Growth Factor II (Somatomedin A)IBA
10/2003
1NBI 31772IBA
10/2003
1LigandsIBA
10/2003
1Insulin-Like Growth Factor Binding ProteinsIBA
10/2003
1Peptides (Polypeptides)IBA
10/2003
1Insulin-Like PeptidesIBA
10/2003

Therapy/Procedure

1Sutures (Suture)
10/2003